Alambic Investment Management, L.P. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 45 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$300,000
-73.5%
51,667
-80.5%
0.24%
-23.5%
Q2 2018$1,133,000
+123.9%
264,665
+207.0%
0.31%
+342.9%
Q1 2018$506,000
+6.8%
86,204
-15.9%
0.07%
+22.8%
Q4 2017$474,000
+203.8%
102,501
+259.7%
0.06%
+235.3%
Q3 2017$156,000
+27.9%
28,500
+35.1%
0.02%
+13.3%
Q2 2017$122,000
+130.2%
21,100
+14.1%
0.02%
-53.1%
Q4 2015$53,00018,5000.03%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders